Prevalence of Extended Spectrum Betalactamase (ESBL) and Metallobetalactamase (MBL) Producing Pseudomonas aeruginosa and Acinetobacter baumannii Isolated from Various Clinical Samples

Table 2

Antimicrobial susceptibility of A. baumannii (N= 116) in relation to various sampling sites.

Name of Antibiotic	ET Secretions; (34)	Tracheal Aspirate; (28)	Pus; (29)	Urine; (9)	Sputum; (7)	Blood; (6)	Various body fluids; (3)
Ceftazidime	0.0%	0.0%	0.0%	22.2%	28.6%	0.0%	0.0%
Cefepime	0.0%	0.0%	3.4%	22.2%	28.6%	0.0%	33.3%
Piperacilllin- Tazobactum	0.0%	3.6%	13.8%	55.6%	28.6%	33.3%	33.3%
Ampicillin-Sulbactum	5.9%	17.9%	41.4%	66.7%	42.9%	33.3%	33.3%
Gentamicin	0.0%	0.0%	10.3%	44.4%	57.1%	0.0%	0.0%
Amikacin	0.0%	0.0%	10.3%	44.4%	42.9%	33.3%	0.0%
Cotrimoxazole	0.0%	0.0%	6.9%	55.6%	28.6%	0.0%	0.0%
Norfloxacin	NT	NT	NT	22.2%	NT	NT	NT
Ciprofloxacin	5.9%	14.3%	13.8%	NT	28.6%	16.7%	0.0%
Imipenem	20.6%	21.4%	75.9%	77.8%	42.9%	0.0%	33.3%
Meropenem	17.6%	21.4%	62.1%	22.2%	57.1%	0.0%	33.3%
Polymyxin B	91.2%	96.4%	100.0%	100.0%	100.0%	100.0%	100.0%
Colistin	94.1%	96.4%	100.0%	100.0%	100.0%	100.0%	100.0%